Deutsch
svenska
dansk
français
polski
português
magyar
suomi
日本語
русский
slovenčina
Tiếng Việt
español
中文
Kannaway Included on New FSA List of CBD Novel Food Applicants
Medical
Marijuana, Inc., the first-ever publicly traded cannabis company in the United
States that launched the world’s first-ever cannabis-derived nutraceutical
products, brands, and supply chain, announced today that its subsidiary Kannaway® has been
included on the recently published list of brands that have submitted Novel
Foods applications to the UK Food Standard Agencies (FSA) for their cannabidiol
(CBD) products.
According to the Association for the Cannabinoid Industry (ACI), the UK’s total sales of CBD products in 2021 was £690
million, making it the second-largest market for consumer CBD, only slightly
behind the U.S.
This new list
contains the names of products that were on the market before February 13,
2020, and have demonstrated a comprehensive toxicological approach to confirm
safety. The FSA states that any companies on this list can continue to market
their products within the UK, and those that are not should discontinue all
sales.
[READ MORE]
